Vaccines and routine immunization strategies during the COVID-19 pandemic

Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatmen...

Full description

Saved in:
Bibliographic Details
Published inHuman vaccines & immunotherapeutics Vol. 17; no. 2; pp. 400 - 407
Main Authors Dinleyici, Ener Cagri, Borrow, Ray, Safadi, Marco Aurélio Palazzi, van Damme, Pierre, Munoz, Flor M.
Format Journal Article
LanguageEnglish
Published United States Taylor & Francis 01.02.2021
Taylor & Francis Group
Subjects
Coronavirus
COVID-19
COVID-19 - epidemiology
COVID-19 - prevention & control
Humans
immunization
Immunization - methods
Immunization - trends
pandemic
Review
Vaccination Coverage - methods
Vaccination Coverage - trends
vaccine
Vaccines - therapeutic use
COVID-19
vaccine
Coronavirus
pandemic
immunization
Online AccessGet full text
ISSN2164-5515
2164-554X
2164-554X
DOI10.1080/21645515.2020.1804776

Cover

Abstract Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatment or vaccine, non-pharmaceutical interventions have been implemented in an attempt to contain the spread of the virus. During times of quarantine, immunization practices in all age groups, especially routine childhood vaccines, have also been interrupted, delayed, re-organized, or completely suspended. Numerous high-income as well as low- and middle-income countries are now experiencing a rapid decline in childhood immunization coverage rates. We will, inevitably, see serious consequences related to suboptimal control of vaccine-preventable diseases (VPDs) in children concurrent with or following the pandemic. Routine pediatric immunizations of individual children at clinics, mass vaccination campaigns, and surveillance for VPDs must continue as much as possible during pandemic.
AbstractList Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatment or vaccine, non-pharmaceutical interventions have been implemented in an attempt to contain the spread of the virus. During times of quarantine, immunization practices in all age groups, especially routine childhood vaccines, have also been interrupted, delayed, re-organized, or completely suspended. Numerous high-income as well as low- and middle-income countries are now experiencing a rapid decline in childhood immunization coverage rates. We will, inevitably, see serious consequences related to suboptimal control of vaccine-preventable diseases (VPDs) in children concurrent with or following the pandemic. Routine pediatric immunizations of individual children at clinics, mass vaccination campaigns, and surveillance for VPDs must continue as much as possible during pandemic.
Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatment or vaccine, non-pharmaceutical interventions have been implemented in an attempt to contain the spread of the virus. During times of quarantine, immunization practices in all age groups, especially routine childhood vaccines, have also been interrupted, delayed, re-organized, or completely suspended. Numerous high-income as well as low- and middle-income countries are now experiencing a rapid decline in childhood immunization coverage rates. We will, inevitably, see serious consequences related to suboptimal control of vaccine-preventable diseases (VPDs) in children concurrent with or following the pandemic. Routine pediatric immunizations of individual children at clinics, mass vaccination campaigns, and surveillance for VPDs must continue as much as possible during pandemic.Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By August 2020, there were almost 20 million confirmed cases worldwide and well over half-million deaths. Since there is still no effective treatment or vaccine, non-pharmaceutical interventions have been implemented in an attempt to contain the spread of the virus. During times of quarantine, immunization practices in all age groups, especially routine childhood vaccines, have also been interrupted, delayed, re-organized, or completely suspended. Numerous high-income as well as low- and middle-income countries are now experiencing a rapid decline in childhood immunization coverage rates. We will, inevitably, see serious consequences related to suboptimal control of vaccine-preventable diseases (VPDs) in children concurrent with or following the pandemic. Routine pediatric immunizations of individual children at clinics, mass vaccination campaigns, and surveillance for VPDs must continue as much as possible during pandemic.
Author Dinleyici, Ener Cagri
Safadi, Marco Aurélio Palazzi
van Damme, Pierre
Borrow, Ray
Munoz, Flor M.
Author_xml – sequence: 1
  givenname: Ener Cagri
  orcidid: 0000-0002-0339-0134
  surname: Dinleyici
  fullname: Dinleyici, Ener Cagri
  email: timboothtr@yahoo.com
  organization: Eskisehir Osmangazi University Faculty of Medicine
– sequence: 2
  givenname: Ray
  surname: Borrow
  fullname: Borrow, Ray
  organization: Public Health England
– sequence: 3
  givenname: Marco Aurélio Palazzi
  orcidid: 0000-0002-4401-9446
  surname: Safadi
  fullname: Safadi, Marco Aurélio Palazzi
  organization: Santa Casa De São Paulo, School of Pediatrics
– sequence: 4
  givenname: Pierre
  surname: van Damme
  fullname: van Damme, Pierre
  organization: University of Antwerp
– sequence: 5
  givenname: Flor M.
  surname: Munoz
  fullname: Munoz, Flor M.
  organization: Baylor College of Medicine
BackLink https://www.ncbi.nlm.nih.gov/pubmed/32845739$$D View this record in MEDLINE/PubMed
BookMark eNqFkV1rFDEYhYNUbK39CcpcerM1n5MMgijr10KhN6V4F97JJNuUmWRNMkr99Wa7u8V6oblJ8uac5xDOc3QUYrAIvST4nGCF31DSciGIOKeY1pHCXMr2CTrZzhdC8G9HD2cijtFZzre4Lokpb9tn6JhRxYVk3QlaXYMxPtjcQBiaFOdSL42fpjn4X1B8DE0uCYpd-6oZ5uTDuik3tlleXq8-LkjXbKrRTt68QE8djNme7fdTdPX509Xy6-Li8stq-eFiYVqMywIkd0p2jPeUWNoBNmB6SgWh1igMUhprnVKs41SwnmPWdj1zQrkOK0NadopWO-wQ4VZvkp8g3ekIXt8PYlprSMWb0WpouXTOkQEryWkNUthYxQQ2YlDCQWW927E2cz_ZwdhQvzo-gj5-Cf5Gr-MPLVXXtVRWwOs9IMXvs81FTz4bO44QbJyzppxJJaigqkpf_Zn1EHKoogre7gQmxZyTddr4ct9AjfajJlhvu9eH7vW2e73vvrrFX-5DwP9873c-H1xME_yMaRx0gbsxJpcgGJ81-zfiN-ahxGA
CitedBy_id crossref_primary_10_1016_j_vaccine_2024_126693
crossref_primary_10_3390_antibiotics10081011
crossref_primary_10_17269_s41997_021_00601_9
crossref_primary_10_3390_jcm11226842
crossref_primary_10_1007_s40200_021_00812_4
crossref_primary_10_29333_ejgm_13150
crossref_primary_10_1016_j_gtc_2023_03_012
crossref_primary_10_1186_s12919_023_00283_w
crossref_primary_10_3390_vaccines11071132
crossref_primary_10_1093_trstmh_trac011
crossref_primary_10_1016_j_jve_2022_100309
crossref_primary_10_3201_eid2813_220088
crossref_primary_10_34172_jrhs_2024_161
crossref_primary_10_1007_s40475_022_00273_6
crossref_primary_10_1080_21645515_2021_2013080
crossref_primary_10_7197_cmj_1035772
crossref_primary_10_1080_21645515_2021_1975453
crossref_primary_10_1016_j_vaccine_2023_06_057
crossref_primary_10_3389_fendo_2022_898810
crossref_primary_10_1016_j_apnr_2023_151717
crossref_primary_10_1016_j_vaccine_2023_12_047
crossref_primary_10_33808_clinexphealthsci_1425189
crossref_primary_10_1080_03007995_2021_1981842
crossref_primary_10_1108_IJHRH_05_2022_0049
crossref_primary_10_1108_JHLSCM_08_2023_0070
crossref_primary_10_1016_j_ypmed_2023_107602
crossref_primary_10_3390_ijerph18020778
crossref_primary_10_9745_GHSP_D_23_00178
crossref_primary_10_2807_1560_7917_ES_2022_27_17_2100167
crossref_primary_10_3390_vaccines11101569
crossref_primary_10_1016_j_tele_2023_101983
crossref_primary_10_12688_f1000research_75537_1
crossref_primary_10_1097_INF_0000000000004622
crossref_primary_10_3390_covid2100097
crossref_primary_10_1136_bmjgh_2023_012203
crossref_primary_10_1159_000530151
crossref_primary_10_1177_21582440251323075
crossref_primary_10_1088_1742_6596_2394_1_012011
crossref_primary_10_1016_j_jinf_2021_11_016
crossref_primary_10_3390_vaccines10030458
crossref_primary_10_1007_s11277_024_11315_9
crossref_primary_10_1016_j_chaos_2024_114932
crossref_primary_10_1080_21645515_2021_1979380
crossref_primary_10_4103_DSHMJ_DSHMJ_2_24
crossref_primary_10_1080_21645515_2023_2251826
crossref_primary_10_1186_s12889_025_21740_5
crossref_primary_10_3390_computation11020036
crossref_primary_10_12956_tchd_982664
crossref_primary_10_1007_s40121_023_00876_0
crossref_primary_10_1016_j_ssmph_2023_101383
crossref_primary_10_1186_s13031_024_00592_7
crossref_primary_10_3390_mca26020025
crossref_primary_10_1136_bmjopen_2023_073272
crossref_primary_10_1016_j_jinf_2022_10_022
crossref_primary_10_1186_s12985_022_01902_2
crossref_primary_10_3390_math11020369
crossref_primary_10_1007_s40121_022_00699_5
crossref_primary_10_37689_acta_ape_2022AO009934
crossref_primary_10_1080_21645515_2020_1849518
crossref_primary_10_1093_milmed_usae323
crossref_primary_10_9745_GHSP_D_21_00310
crossref_primary_10_1080_21645515_2022_2071079
crossref_primary_10_1016_j_jddst_2025_106741
crossref_primary_10_1016_j_scitotenv_2022_156518
crossref_primary_10_1080_14760584_2024_2360212
crossref_primary_10_3390_ijms252312708
crossref_primary_10_1016_j_health_2024_100318
crossref_primary_10_1177_1942602X211033516
crossref_primary_10_1371_journal_pone_0307479
crossref_primary_10_3389_fcomm_2022_1004139
crossref_primary_10_1001_jamanetworkopen_2023_22588
crossref_primary_10_1007_s13312_020_2071_8
crossref_primary_10_1016_j_jebo_2023_05_012
crossref_primary_10_1016_j_vaccine_2024_01_106
crossref_primary_10_1590_1518_8345_6285_3805
crossref_primary_10_1590_1518_8345_6285_3803
crossref_primary_10_1590_1518_8345_6285_3804
crossref_primary_10_7759_cureus_42563
crossref_primary_10_1111_jpc_15805
crossref_primary_10_1103_PhysRevE_103_042316
crossref_primary_10_1177_00333549241297685
crossref_primary_10_1186_s12879_021_06357_4
crossref_primary_10_1186_s12889_024_20591_w
crossref_primary_10_1016_j_jadohealth_2023_01_004
crossref_primary_10_1136_bmjgh_2021_006874
crossref_primary_10_14295_jmphc_v15_1332
crossref_primary_10_1080_20477724_2024_2439740
crossref_primary_10_4102_hts_v78i4_7308
crossref_primary_10_1371_journal_pone_0301488
crossref_primary_10_1080_14760584_2024_2441250
crossref_primary_10_2196_57384
crossref_primary_10_1016_j_jvacx_2023_100383
crossref_primary_10_33880_ejfm_2023120207
crossref_primary_10_3390_covid2030026
crossref_primary_10_3390_healthcare11030393
crossref_primary_10_3390_ijerph191711044
crossref_primary_10_1016_j_lanwpc_2021_100156
crossref_primary_10_1186_s12889_024_20854_6
crossref_primary_10_1186_s12916_022_02277_5
crossref_primary_10_1016_j_vaccine_2023_12_080
crossref_primary_10_3390_vaccines13010006
crossref_primary_10_1016_j_vaccine_2020_12_080
crossref_primary_10_1007_s40475_022_00271_8
crossref_primary_10_1093_heapro_daab034
crossref_primary_10_1080_21645515_2023_2199656
crossref_primary_10_3390_healthcare11202767
crossref_primary_10_3390_vaccines11030516
crossref_primary_10_3389_fped_2021_666848
crossref_primary_10_1177_2752535X241256414
crossref_primary_10_1016_j_jik_2022_100171
crossref_primary_10_15406_bbij_2024_13_00416
crossref_primary_10_3389_fmed_2022_829799
crossref_primary_10_3390_vaccines11101524
crossref_primary_10_1002_hsr2_516
crossref_primary_10_3389_fimmu_2022_1080408
crossref_primary_10_54393_fbt_v3i02_47
crossref_primary_10_1001_jamanetworkopen_2022_42853
crossref_primary_10_1097_INF_0000000000004149
crossref_primary_10_3390_epidemiologia2030021
crossref_primary_10_1007_s40314_021_01592_6
crossref_primary_10_1080_21645515_2021_1972708
crossref_primary_10_3390_vaccines11040720
crossref_primary_10_1016_j_imu_2023_101329
crossref_primary_10_1093_trstmh_trab133
crossref_primary_10_4081_jphr_2021_2588
crossref_primary_10_1590_0102_311xen074723
crossref_primary_10_3389_fpubh_2024_1291495
crossref_primary_10_1016_j_jped_2022_12_003
crossref_primary_10_1002_emp2_12814
crossref_primary_10_1055_a_1905_4966
crossref_primary_10_1016_j_anpedi_2021_11_008
crossref_primary_10_1177_11786329231189407
crossref_primary_10_2139_ssrn_3571766
crossref_primary_10_1007_s40121_024_01063_5
crossref_primary_10_3390_vaccines11040730
crossref_primary_10_1016_j_jpeds_2022_09_035
crossref_primary_10_1111_ppe_70000
crossref_primary_10_1111_apa_15949
crossref_primary_10_22207_JPAM_17_1_30
crossref_primary_10_1016_j_tmaid_2022_102352
crossref_primary_10_1016_j_anpede_2021_11_001
crossref_primary_10_1016_j_ssaho_2024_100844
crossref_primary_10_31631_2073_3046_2021_20_5_21_31
crossref_primary_10_1080_21645515_2022_2102353
crossref_primary_10_3390_epidemiologia2020012
crossref_primary_10_1177_25151355241288115
crossref_primary_10_1200_GO_23_00477
crossref_primary_10_1186_s12889_024_19860_5
crossref_primary_10_3390_electronics12010154
crossref_primary_10_3390_healthcare9050528
crossref_primary_10_17816_brmma508783
crossref_primary_10_4103_jfmpc_jfmpc_1899_23
crossref_primary_10_32322_jhsm_1062666
crossref_primary_10_1016_j_pedhc_2021_04_012
crossref_primary_10_1080_07853890_2021_2009128
crossref_primary_10_1016_j_vaccine_2021_08_044
crossref_primary_10_1177_23743735221113160
crossref_primary_10_1016_j_puhe_2023_02_017
crossref_primary_10_1186_s12889_023_15975_3
crossref_primary_10_2471_BLT_21_285877
crossref_primary_10_1155_2021_6995096
crossref_primary_10_1186_s12913_023_09812_x
crossref_primary_10_3389_fped_2022_926013
crossref_primary_10_1016_j_cegh_2024_101816
crossref_primary_10_1177_10541373221118149
crossref_primary_10_1136_bmj_n3093
crossref_primary_10_1080_14760584_2022_2116007
crossref_primary_10_3390_vaccines11121776
crossref_primary_10_1016_j_pec_2024_108556
crossref_primary_10_1108_JHLSCM_09_2021_0091
crossref_primary_10_1186_s13031_022_00465_x
crossref_primary_10_1080_23288604_2022_2156043
crossref_primary_10_1038_s41541_022_00447_3
crossref_primary_10_1080_0144929X_2022_2059397
crossref_primary_10_3390_vaccines12010020
Cites_doi 10.1001/jamainternmed.2020.0994
10.1001/jama.2020.5394
10.1136/thoraxjnl-2015-206780
10.1038/d41586-020-01011-6
10.15585/mmwr.mm6919e2
10.1101/2020.03.24.20042937
10.1126/science.368.6486.14
10.1016/j.ijid.2020.03.030
10.1056/NEJMc2003717
10.1016/S2468-2667(20)30073-6
10.1016/S2468-2667(20)30082-7
10.1126/science.abc4262
10.1016/j.jped.2020.04.001
10.1016/S0140-6736(17)31463-0
10.1016/S2352-4642(20)30177-2
10.1126/science.368.6487.116
10.1002/jmv.25781
10.1136/bmj.m2392
10.1016/j.cell.2020.04.042
10.1016/s0264-410x(03)00181-6
10.1001/jama.2020.10802
10.1186/s41182-020-00219-6
10.1038/d41573-020-00073-5
10.1186/1471-2334-9-187
10.15585/mmwr.mm6920e1
10.1126/science.363.6428.677
10.3855/jidc.12600
10.1016/j.coviro.2020.01.001
10.1097/QCO.0000000000000347
10.1016/j.cmi.2019.04.020.E
10.1016/j.jpeds.2020.06.044
10.1016/S2213-2600(20)30079-5
10.1001/jamapediatrics.2020.1346
10.1101/2020.05.19.20106278
10.15585/mmwr.mm6914e4
10.1016/S0140-6736(20)30791-1
10.1097/INF.0000000000002599
10.1016/j.immuni.2020.03.007
10.1136/bmj.m57
10.1016/S0140-6736(20)30763-7
10.1126/science.367.6473.14
10.1016/j.tmaid.2019.04.003
10.1101/2020.04.11.20062232
10.1016/S0140-6736(20)30461-X
10.1016/S1473-3099(20)30304-2
10.1016/S0140-6736(20)30566-3
10.1371/currents.RRN1119
10.1097/INF.0000000000002688
10.1016/S2352-4642(20)30095-X
ContentType Journal Article
Copyright 2020 Taylor & Francis Group, LLC 2020
2020 Taylor & Francis Group, LLC 2020 Taylor & Francis
Copyright_xml – notice: 2020 Taylor & Francis Group, LLC 2020
– notice: 2020 Taylor & Francis Group, LLC 2020 Taylor & Francis
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOA
DOI 10.1080/21645515.2020.1804776
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate E. C. DINLEYICI ET AL
EISSN 2164-554X
EndPage 407
ExternalDocumentID oai_doaj_org_article_a647fff1d087420ca80ce8350c5d85fa
PMC7899627
32845739
10_1080_21645515_2020_1804776
1804776
Genre Review
Journal Article
GroupedDBID ---
00X
0YH
30N
4.4
53G
AALUX
ABEIZ
ABUPF
ACENM
ACGFS
ADBBV
ADCVX
AECIN
AENEX
AEXWM
AGYJP
AIJEM
ALMA_UNASSIGNED_HOLDINGS
ALQZU
AOIJS
ARJSQ
BABNJ
BAWUL
BLEHA
BOHLJ
CCCUG
DGEBU
DIK
EBS
H13
HYE
IPNFZ
KYCEM
LJTGL
M4Z
O9-
RIG
RPM
TDBHL
TFL
TFW
TTHFI
0VX
AAYXX
CITATION
EJD
EMOBN
GROUPED_DOAJ
OVD
SV3
TEORI
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c600t-a74f87934b21e29a0cacb22512ec80a77ceef88394253b40369b3f58f908c163
IEDL.DBID DOA
ISSN 2164-5515
2164-554X
IngestDate Wed Aug 27 00:49:17 EDT 2025
Thu Aug 21 13:38:45 EDT 2025
Fri Jul 11 05:18:46 EDT 2025
Thu Apr 03 07:05:31 EDT 2025
Tue Jul 01 02:46:12 EDT 2025
Thu Apr 24 22:50:53 EDT 2025
Wed Dec 25 09:06:36 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords COVID-19
vaccine
Coronavirus
pandemic
immunization
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c600t-a74f87934b21e29a0cacb22512ec80a77ceef88394253b40369b3f58f908c163
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-4401-9446
0000-0002-0339-0134
OpenAccessLink https://doaj.org/article/a647fff1d087420ca80ce8350c5d85fa
PMID 32845739
PQID 2437852528
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_7899627
crossref_primary_10_1080_21645515_2020_1804776
doaj_primary_oai_doaj_org_article_a647fff1d087420ca80ce8350c5d85fa
pubmed_primary_32845739
crossref_citationtrail_10_1080_21645515_2020_1804776
proquest_miscellaneous_2437852528
informaworld_taylorfrancis_310_1080_21645515_2020_1804776
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2021-02-01
PublicationDateYYYYMMDD 2021-02-01
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-01
  day: 01
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Human vaccines & immunotherapeutics
PublicationTitleAlternate Hum Vaccin Immunother
PublicationYear 2021
Publisher Taylor & Francis
Taylor & Francis Group
Publisher_xml – name: Taylor & Francis
– name: Taylor & Francis Group
References e_1_3_2_28_1
e_1_3_2_49_1
e_1_3_2_20_1
e_1_3_2_41_1
e_1_3_2_66_1
e_1_3_2_22_1
e_1_3_2_43_1
e_1_3_2_64_1
e_1_3_2_24_1
e_1_3_2_45_1
e_1_3_2_26_1
e_1_3_2_47_1
e_1_3_2_68_1
e_1_3_2_62_1
e_1_3_2_60_1
e_1_3_2_16_1
e_1_3_2_39_1
e_1_3_2_9_1
e_1_3_2_18_1
e_1_3_2_7_1
e_1_3_2_31_1
e_1_3_2_54_1
e_1_3_2_77_1
e_1_3_2_10_1
e_1_3_2_33_1
e_1_3_2_52_1
e_1_3_2_75_1
e_1_3_2_12_1
e_1_3_2_35_1
e_1_3_2_58_1
e_1_3_2_5_1
e_1_3_2_14_1
e_1_3_2_37_1
e_1_3_2_56_1
e_1_3_2_79_1
e_1_3_2_3_1
e_1_3_2_50_1
e_1_3_2_73_1
e_1_3_2_71_1
e_1_3_2_27_1
e_1_3_2_29_1
e_1_3_2_42_1
e_1_3_2_65_1
e_1_3_2_21_1
e_1_3_2_44_1
e_1_3_2_63_1
e_1_3_2_23_1
e_1_3_2_46_1
e_1_3_2_69_1
e_1_3_2_25_1
e_1_3_2_48_1
e_1_3_2_67_1
e_1_3_2_61_1
e_1_3_2_40_1
e_1_3_2_17_1
e_1_3_2_38_1
e_1_3_2_8_1
e_1_3_2_19_1
e_1_3_2_2_1
e_1_3_2_30_1
e_1_3_2_55_1
e_1_3_2_76_1
e_1_3_2_11_1
e_1_3_2_32_1
e_1_3_2_53_1
e_1_3_2_74_1
e_1_3_2_6_1
e_1_3_2_13_1
e_1_3_2_34_1
e_1_3_2_59_1
e_1_3_2_4_1
e_1_3_2_15_1
e_1_3_2_36_1
e_1_3_2_57_1
e_1_3_2_78_1
e_1_3_2_51_1
e_1_3_2_72_1
e_1_3_2_70_1
References_xml – ident: e_1_3_2_5_1
  doi: 10.1001/jamainternmed.2020.0994
– ident: e_1_3_2_4_1
  doi: 10.1001/jama.2020.5394
– ident: e_1_3_2_67_1
– ident: e_1_3_2_45_1
  doi: 10.1136/thoraxjnl-2015-206780
– ident: e_1_3_2_27_1
  doi: 10.1038/d41586-020-01011-6
– ident: e_1_3_2_37_1
  doi: 10.15585/mmwr.mm6919e2
– ident: e_1_3_2_57_1
  doi: 10.1101/2020.03.24.20042937
– ident: e_1_3_2_44_1
– ident: e_1_3_2_78_1
  doi: 10.1126/science.368.6486.14
– ident: e_1_3_2_53_1
  doi: 10.1016/j.ijid.2020.03.030
– ident: e_1_3_2_70_1
– ident: e_1_3_2_52_1
– ident: e_1_3_2_11_1
  doi: 10.1056/NEJMc2003717
– ident: e_1_3_2_8_1
  doi: 10.1016/S2468-2667(20)30073-6
– ident: e_1_3_2_49_1
  doi: 10.1016/S2468-2667(20)30082-7
– ident: e_1_3_2_55_1
  doi: 10.1126/science.abc4262
– ident: e_1_3_2_35_1
– ident: e_1_3_2_17_1
  doi: 10.1016/j.jped.2020.04.001
– ident: e_1_3_2_33_1
  doi: 10.1016/S0140-6736(17)31463-0
– ident: e_1_3_2_21_1
– ident: e_1_3_2_66_1
– ident: e_1_3_2_15_1
  doi: 10.1016/S2352-4642(20)30177-2
– ident: e_1_3_2_75_1
  doi: 10.1126/science.368.6487.116
– ident: e_1_3_2_51_1
  doi: 10.1002/jmv.25781
– ident: e_1_3_2_42_1
  doi: 10.1136/bmj.m2392
– ident: e_1_3_2_23_1
– ident: e_1_3_2_54_1
  doi: 10.1016/j.cell.2020.04.042
– ident: e_1_3_2_61_1
  doi: 10.1016/s0264-410x(03)00181-6
– ident: e_1_3_2_48_1
  doi: 10.1001/jama.2020.10802
– ident: e_1_3_2_3_1
– ident: e_1_3_2_59_1
– ident: e_1_3_2_73_1
  doi: 10.1186/s41182-020-00219-6
– ident: e_1_3_2_26_1
– ident: e_1_3_2_56_1
– ident: e_1_3_2_79_1
  doi: 10.1038/d41573-020-00073-5
– ident: e_1_3_2_20_1
  doi: 10.1186/1471-2334-9-187
– ident: e_1_3_2_38_1
  doi: 10.15585/mmwr.mm6920e1
– ident: e_1_3_2_29_1
  doi: 10.1126/science.363.6428.677
– ident: e_1_3_2_12_1
  doi: 10.3855/jidc.12600
– ident: e_1_3_2_31_1
  doi: 10.1016/j.coviro.2020.01.001
– ident: e_1_3_2_64_1
– ident: e_1_3_2_39_1
– ident: e_1_3_2_47_1
– ident: e_1_3_2_46_1
  doi: 10.1097/QCO.0000000000000347
– ident: e_1_3_2_60_1
  doi: 10.1016/j.cmi.2019.04.020.E
– ident: e_1_3_2_16_1
  doi: 10.1016/j.jpeds.2020.06.044
– ident: e_1_3_2_25_1
– ident: e_1_3_2_41_1
– ident: e_1_3_2_10_1
– ident: e_1_3_2_69_1
– ident: e_1_3_2_2_1
  doi: 10.1016/S2213-2600(20)30079-5
– ident: e_1_3_2_63_1
– ident: e_1_3_2_13_1
  doi: 10.1001/jamapediatrics.2020.1346
– ident: e_1_3_2_36_1
  doi: 10.1101/2020.05.19.20106278
– ident: e_1_3_2_14_1
  doi: 10.15585/mmwr.mm6914e4
– ident: e_1_3_2_32_1
– ident: e_1_3_2_74_1
  doi: 10.1016/S0140-6736(20)30791-1
– ident: e_1_3_2_24_1
– ident: e_1_3_2_34_1
  doi: 10.1097/INF.0000000000002599
– ident: e_1_3_2_77_1
  doi: 10.1016/j.immuni.2020.03.007
– ident: e_1_3_2_40_1
– ident: e_1_3_2_30_1
  doi: 10.1136/bmj.m57
– ident: e_1_3_2_76_1
  doi: 10.1016/S0140-6736(20)30763-7
– ident: e_1_3_2_22_1
  doi: 10.1126/science.367.6473.14
– ident: e_1_3_2_28_1
  doi: 10.1016/j.tmaid.2019.04.003
– ident: e_1_3_2_71_1
– ident: e_1_3_2_43_1
– ident: e_1_3_2_58_1
  doi: 10.1101/2020.04.11.20062232
– ident: e_1_3_2_65_1
– ident: e_1_3_2_68_1
– ident: e_1_3_2_62_1
– ident: e_1_3_2_72_1
  doi: 10.1016/S0140-6736(20)30461-X
– ident: e_1_3_2_9_1
  doi: 10.1016/S1473-3099(20)30304-2
– ident: e_1_3_2_6_1
  doi: 10.1016/S0140-6736(20)30566-3
– ident: e_1_3_2_19_1
  doi: 10.1371/currents.RRN1119
– ident: e_1_3_2_50_1
  doi: 10.1097/INF.0000000000002688
– ident: e_1_3_2_18_1
  doi: 10.1016/S2352-4642(20)30095-X
– ident: e_1_3_2_7_1
SSID ssj0000702466
Score 2.59399
SecondaryResourceType review_article
Snippet Severe acute respiratory syndrome coronavirus 2 related disease (COVID-19) is now responsible for one of the most challenging and concerning pandemics. By...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
informaworld
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 400
SubjectTerms Coronavirus
COVID-19
COVID-19 - epidemiology
COVID-19 - prevention & control
Humans
immunization
Immunization - methods
Immunization - trends
pandemic
Review
Vaccination Coverage - methods
Vaccination Coverage - trends
vaccine
Vaccines - therapeutic use
Title Vaccines and routine immunization strategies during the COVID-19 pandemic
URI https://www.tandfonline.com/doi/abs/10.1080/21645515.2020.1804776
https://www.ncbi.nlm.nih.gov/pubmed/32845739
https://www.proquest.com/docview/2437852528
https://pubmed.ncbi.nlm.nih.gov/PMC7899627
https://doaj.org/article/a647fff1d087420ca80ce8350c5d85fa
Volume 17
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB5BJSQuiDfhURmJq6nj2LFzhELVciiXUvVm2Y4tVoJs1U0P_HvGdrLKVkh74TqJJXs8k_kmHn8D8CFIFqVjPW273lPRhpba1jpaOydqxzMneKq2OG9Pf4hvV_Jq0eor1YQVeuCiuCPbChVjrHumMYtj3mrmA8IG5mWvZczQCGPeIpnK32CFsScfVHLMByjCAjlf39HsKMmSCNNDjiLNhEqcI4vAlPn777CX_guD3i2lXMSmk8fwaAKV5FNZzBO4F4an8KC0mfzzDM4urU_n5xtih57crNHWhkBW-WZIuYVJNuNMGUHKxUWCwJAcf788-0LrjlynX82_V_45XJx8vTg-pVMLBeoRyYzUKhE1uqBwvA68s6g_n3ag5sFrZpXCGBk1giR03cYJDGeda6LUsWPaI1R7AQfDegivgOimb2IvfWKrEQ5hnVOxx51B-Og6rn0FYlaf8RO9eOpy8cvUEwvprHWTtG4mrVfwcTvsuvBr7BvwOe3N9uVEj50FaDRmMhqzz2gq6JY7a8b8dySWViam2TOB97MZGHTFdL5ih7C-3ZjE7agll1xX8LKYxXaaDcIAqZquArVjMDvr2H0yrH5mum-FKXHL1ev_sfA38JCnopxcdv4WDsab2_AOUdXoDuF-w84Psxv9BZ0HGM4
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nk9MgFGd0HUcvfrvGT5zxmkoIBDjq6k6ra73Unb0xQEA7rulOmx70r_cRkk7b0dnDXklI4PEe7we89wOhN56TwC2p80rVLmeVr3JTGZsX1rLC0o4TPEZbTKvxN_bpjJ9t5cLEsMq4hg6JKKKbq6Nxx83oISTuLQWMD56ew_KOQpEkTIjqOrrBVSWicZZkutlnAZWm6cgy1spjtSGR539f2nFRHZP_Ho_pv9DoflDllpc6vovc0L8UnPJztG7tyP3Zo368mgDuoTs9iMXvktbdR9d88wDdTNda_n6IJqfGxfP6FYY_4OUCdLvxeN5loqSsT7xqB4oKnBIlMQBRfPT1dPIhLxS-iFvbv-buEZodf5wdjfP-yobcAXJqcyNYkGDyzNLCU2WIMy6OeEG9k8QIAT45SABlMFWUloH7VLYMXAZFpANo-BgdNIvGP0FYlnUZau4iOw6zACOtCLUIAeCqVVS6DLFhkLTr6czjrRrnuuhZTwch6Sgk3QspQ6NNtYvE53FZhfdRAzYvRzrurmCx_K5769amYtC0UNRECkah05I4D9iWOF5LHkyG1Lb-6LbbjQnp6hRdXtKA14OyaTD9eJ5jGr9Yr3TkkpScciozdJiUb9PMEmAHF6XKkNhRy51-7D5p5j86enEBS_CKiqdXaPMrdGs8-3KiTybTz8_QbRrjgLpI9-fooF2u_QsAcq192VnqX1IFN8s
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB7BIhAX3o_yNBLXFMexY-cIu1RbQIXDsuJm2Y69VEBatekBfj3jOKm2FWgPe3XixI8Zz2fPzGeA117QICyts7KqXcZLX2amNDbLreW5ZR0neIy2mJXHX_mHb2KIJlz3YZVxDx0SUUS3VkflXtZhiIh7wxDio6EXuLtjWKQol7K8CtfK6OSLWRx0tj1mQYlmyWMZa2Wx2pDH878v7Viojsh_j8b0X2B0P6bynJGa3AY7dC_FpvwYb1o7dn_2mB8v1f87cKuHsORtkrm7cMU39-B6utTy932YnhoXvfVrgj8gqwVKduPJvMtDSTmfZN0OBBUkpUkShKHk8PPp9CjLK7KMB9u_5u4BnEzenxweZ_2FDZlD3NRmRvKgUOG5ZblnlaHOuDjfOfNOUSMlWuSgEJLhQlFYjsazskUQKlRUOQSGD-GgWTT-MRBV1EWohYvcONwiiLQy1DIEBKu2YsqNgA9zpF1PZh7v1Pip857zdBgkHQdJ94M0gvG22jKxeVxU4V0UgO3LkYy7K1isznSv29qUHJsW8poqyRl2WlHnEdlSJ2olghlBdV58dNudxYR0cYouLmjAq0HWNCp-9OaYxi82ax2ZJJVggqkRPEqyt21mgaBDyKIagdyRyp1-7D5p5t87cnGJG_CSySeXaPNLuPHlaKI_TWcfn8JNFoOAujD3Z3DQrjb-OaK41r7o9PQvQnQ2bw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Vaccines+and+routine+immunization+strategies+during+the+COVID-19+pandemic&rft.jtitle=Human+vaccines+%26+immunotherapeutics&rft.au=Dinleyici%2C+Ener+Cagri&rft.au=Borrow%2C+Ray&rft.au=Safadi%2C+Marco+Aur%C3%A9lio+Palazzi&rft.au=van+Damme%2C+Pierre&rft.date=2021-02-01&rft.issn=2164-5515&rft.eissn=2164-554X&rft.volume=17&rft.issue=2&rft.spage=400&rft.epage=407&rft_id=info:doi/10.1080%2F21645515.2020.1804776&rft.externalDBID=n%2Fa&rft.externalDocID=10_1080_21645515_2020_1804776
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2164-5515&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2164-5515&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2164-5515&client=summon